Literature DB >> 3855473

Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure.

P L Ostrander, K T Mills, H A Bern.   

Abstract

The effects of ovariectomy at 1 month of age and continuous 17 beta-estradiol (E2) and/or progesterone (P) replacement on the uterus of BALB/cCrgl mice neonatally treated with diethylstilbestrol [(DES) CAS: 56-53-1; alpha-alpha'-diethyl-4,4'-stilbenediol] or sesame oil were recorded after 1, 4, 7, and 10 months of treatment. DES-exposed uteri were found to be hypoplastic, less responsive to the growth-promoting effects of E2, and more likely to develop smooth muscle abnormalities after continuous hormonal treatment than similarly treated control uteri. Neonatal DES treatment led to leukocytic infiltration, disruption in the organization of the inner circular smooth muscle layer, and development of a population of epithelial cells believed to respond to later E2 treatment by proliferation and stratification (squamous metaplasia). Qualitative and quantitative responses to continuous P treatment and the development of cystic glandular hyperplasia and adenomyosis were found to be unaltered by neonatal DES administration. The relevance of these results to the problems of uterine abnormalities observed in women exposed to DES in utero is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855473

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  SIX1 Regulates Aberrant Endometrial Epithelial Cell Differentiation and Cancer Latency Following Developmental Estrogenic Chemical Exposure.

Authors:  Alisa A Suen; Wendy N Jefferson; Charles E Wood; Carmen J Williams
Journal:  Mol Cancer Res       Date:  2019-10-09       Impact factor: 5.852

2.  Adenomyosis with severe inflammation in the uterine cervix in a dog.

Authors:  Hiromichi Tamada; Noritoshi Kawate; Toshio Inaba; Mitsuru Kuwamura; Masaya Maeda; Taketsugu Kajikawa; Tsutomu Sawada
Journal:  Can Vet J       Date:  2005-04       Impact factor: 1.008

3.  Abnormalities in the reproductive system of aged mice after neonatal estradiol exposure.

Authors:  T Mori
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

4.  SIX1 Oncoprotein as a Biomarker in a Model of Hormonal Carcinogenesis and in Human Endometrial Cancer.

Authors:  Alisa A Suen; Wendy N Jefferson; Charles E Wood; Elizabeth Padilla-Banks; Victoria L Bae-Jump; Carmen J Williams
Journal:  Mol Cancer Res       Date:  2016-06-03       Impact factor: 5.852

5.  Differentiation Patterns of Uterine Carcinomas and Precursor Lesions Induced by Neonatal Estrogen Exposure in Mice.

Authors:  Alisa A Suen; Wendy N Jefferson; Carmen J Williams; Charles E Wood
Journal:  Toxicol Pathol       Date:  2018-06-12       Impact factor: 1.902

6.  Animal Models of Adenomyosis.

Authors:  Ryan M Marquardt; Jae-Wook Jeong; Asgerally T Fazleabas
Journal:  Semin Reprod Med       Date:  2020-10-26       Impact factor: 1.303

7.  β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition.

Authors:  Seo Jin Oh; Jung-Ho Shin; Tae Hoon Kim; Hee Sun Lee; Jung-Yoon Yoo; Ji Yeon Ahn; Russell R Broaddus; Makoto M Taketo; John P Lydon; Richard E Leach; Bruce A Lessey; Asgerally T Fazleabas; Jeong Mook Lim; Jae-Wook Jeong
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

8.  Developmental effects of prenatal exposure to bisphenol a on the uterus of rat offspring.

Authors:  Gilbert Schönfelder; Karin Friedrich; Martin Paul; Ibrahim Chahoud
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

Review 9.  Organization versus activation: the role of endocrine-disrupting contaminants (EDCs) during embryonic development in wildlife.

Authors:  L J Guillette; D A Crain; A A Rooney; D B Pickford
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

Review 10.  The Pathogenesis of Adenomyosis vis-à-vis Endometriosis.

Authors:  Sun-Wei Guo
Journal:  J Clin Med       Date:  2020-02-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.